IP Forum
The Intellectual Property Forum is held to facilitate a broad exchange of views with experts and stakeholders on various intellectual property issues facing the pharmaceutical industry as it continues to develop within the international community, with the aim of disseminating the JPMA’s recommendations on intellectual property and working toward their implementation.
Past Events
-
2026 Life Sciences Intellectual Property Forum
The Future of the Pharmaceutical Industry Amid Advancing Digitalization and the Increasingly Common Use of AI
-
2025 Life Sciences Intellectual Property Forum
Intellectual Property Practices at a Turning Point: What Is Required of the Professionals Who Handle Them
-
2024 Life Sciences Intellectual Property Forum
Now Is the Time to Strengthen Japan’s Drug Discovery Capabilities! —Toward Building a Resilient Drug Discovery Ecosystem for New Modalities—
-
2023 Life Sciences IP Forum
—Current Status, Outlook, and Challenges of Digital Therapeutics (DTx)—
-
2022 Life Sciences IP Forum
—Challenges in the Innovation Ecosystem Revealed by the COVID-19 Pandemic and Prospects for Solutions—
-
2021 Life Sciences IP Forum
Handling Intellectual Property Rights in Pandemic Response Measures, Including COVID-19
-
2020 Life Sciences IP Forum
How to Protect New Businesses Where Digital Data Is the Source of Value: Multifaceted Protection Through Intellectual Property and Contracts
-
2019 Life Sciences IP Forum
The New Drug Business and Intellectual Property in China
-
2018 Life Sciences IP Forum
The Life Sciences Revolution Driven by AI and Big Data: The Future of Healthcare and Drug Discovery—Potential and Challenges—
-
2017 Life Sciences IP Forum
The Paradigm Shift in Intellectual Property and Business Strategies Brought About by Regenerative Medicine
-
2016 Life Sciences Intellectual Property Forum
Strong Patents and Changes in the Dispute Resolution Environment for the Development of the Life Sciences Industry